Aethlon Medical
AEMD
22 hedge funds and large institutions have $1.09M invested in Aethlon Medical in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 22 → 22 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
41% less capital invested
Capital invested by funds: $1.85M → $1.09M (-$760K)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| 1 |
N
Natixis
Paris,
France
|
+$28.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$14.9K |
| 3 |
Truist Financial
Charlotte,
North Carolina
|
+$13K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$12.1K |
| 5 |
Citigroup
New York
|
+$8.38K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$395K |
| 2 |
Two Sigma Investments
New York
|
-$40K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$30.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$15.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Two Sigma Investments
New York
| – | -$40K | -35 | Closed |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$17K | -15 | Closed |
|
|
CFO
28
CVA Family Office
Denver,
Colorado
| – | -$1K | -1 | Closed |
|
AEMD Hedge Fund Activity: Q2 2022 in Review
22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2022, worth a combined $1.09M — down 41% from $1.85M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AEMD positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Natixis, opening a new position worth an estimated $28.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $395K sold.
- 22 institutional investors held Aethlon Medical (AEMD) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.09M of Aethlon Medical stock for Q2 2022, down 41% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q2 2022 and 4 closed out, a net change of +1 holder.
- The largest Aethlon Medical buyer in Q2 2022 was Natixis, an estimated $28.9K added.
- The largest Aethlon Medical seller in Q2 2022 was Renaissance Technologies, an estimated $395K sold.
Based on aggregated 13F filings for Q2 2022.